Periodic update on transaction details related to Philips’ share repurchases

Aug 23, 2024 | 1 minute read

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from August 14, 2024 up to and including August 22, 2024 a total of 900,080 of its own common shares were repurchased, with a weighted average purchase price of EUR 26.36. These repurchases were made under the repurchase program to cover certain of the company’s obligations arising from its long-term incentive plans, which was announced on August 5, 2024. Since the start of the program, Philips also entered into a forward transaction with a settlement date in November 2026.

Further details can be found via this link.

About Royal Philips

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 68,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.